Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).
NCT05542615
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Liver Cirrhosis
Hepatitis C, Chronic
Epigenetic Disorder
Interventions
DRUG:
Prolonged-Release Pirfenidone
Sponsor
University of Guadalajara
Collaborators
[object Object]